Hope for TB patients as doctors call for reduction in drug price

A medical worker at mobile testing facilities for Tuberculosis (TB) at Driefontein Gold Mine in South Africa. MSF has said lowering the price of bedaquiline will enable a scale-up of drug-resistant treatment and reduction of deaths. PHOTO | AFP

A global campaign has been launched, calling on pharmaceutical corporation Johnson & Johnson (J & J) to lower the price of its anti-tuberculosis medicine bedaquiline to no more than US$1 per day (about Sh 100) for people who need it around the world.

Welcome!

You're all set to enjoy unlimited Prime content.